AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Briones, M Singh, M Ugozzoli, M Kazzaz, J Klakamp, S Ott, G O'Hagan, D
Citation: M. Briones et al., The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery, PHARM RES, 18(5), 2001, pp. 709-712

Authors: Singh, M Ott, G Kazzaz, J Ugozzoli, M Briones, M Donnelly, J O'Hagan, DT
Citation: M. Singh et al., Cationic microparticles are an effective delivery system for immune stimulatory CpG DNA, PHARM RES, 18(10), 2001, pp. 1476-1479

Authors: O'Hagan, D Singh, M Ugozzoli, M Wild, C Barnett, S Chen, MC Schaefer, M Doe, B Otten, GR Ulmer, JB
Citation: D. O'Hagan et al., Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines, J VIROLOGY, 75(19), 2001, pp. 9037-9043

Authors: Ugozzoli, M Santos, G Donnelly, J O'Hagan, DT
Citation: M. Ugozzoli et al., Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant, J INFEC DIS, 183(2), 2001, pp. 351-354

Authors: Greer, CE Petracca, R Buonamassa, DT Di Tommaso, A Gervase, B Reeve, RL Ugozzoli, M Van Nest, G De Magistris, MT Bensi, G
Citation: Ce. Greer et al., The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles, VACCINE, 19(9-10), 2000, pp. 1008-1012

Authors: O'Hagan, DT Ugozzoli, M Barackman, J Singh, M Kazzaz, J Higgins, K Vancott, TC Ott, G
Citation: Dt. O'Hagan et al., Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1, VACCINE, 18(17), 2000, pp. 1793-1801

Authors: Neidleman, JA Vajdy, M Ugozzoli, M Ott, G O'Hagan, D
Citation: Ja. Neidleman et al., Genetically detoxified mutants of heat-labile enterotoxin from Escherichiacoli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55, IMMUNOLOGY, 101(1), 2000, pp. 154-160

Authors: O'Hagan, D Goldbeck, C Ugozzoli, M Ott, G Burke, RL
Citation: D. O'Hagan et al., Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs, VACCINE, 17(18), 1999, pp. 2229-2236
Risultati: 1-8 |